Myriad Genetics | MYGN - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Agilent USD 6.91B 167M 2025-12
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Danaher USD 52.95B 415M 2026-03
Illumina USD 2.68B 47M 2026-03
J&J USD 81.19B 358M 2026-03
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
OraSure Technologies USD 313.32M 27.5M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 666K 2026-03
Revvity USD 7.25B 125.54M 2025-12
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.34B 34.83M 2026-03
Waters USD 2.56B 230.55M 2025-12